Market Insights Health Pharmaceuticals Vaccines

COVID-19 Vaccines - Uganda

Uganda

The COVID-19 Vaccines market in Uganda is expected to achieve a revenue of US$81.73m in 2024.
Furthermore, it is projected to exhibit a compound annual growth rate (CAGR 2024-2029) of -17.84%, leading to a market volume of US$30.59m by 2029.
When comparing this to other countries on a global scale, United States is anticipated to generate the highest revenue, amounting to US$4,389,000.00k in 2024.
Uganda is experiencing a surge in demand for COVID-19 vaccines, as the government intensifies efforts to vaccinate its population and curb the spread of the virus.

Key regions: United Kingdom, Germany, France, South Korea, Italy

Market

Region

Region comparison

Currency

Analyst Opinion

Uganda, a country in East Africa, has been making significant progress in its battle against COVID-19. The country has been able to vaccinate a significant portion of its population, and the COVID-19 vaccine market in Uganda has been developing in a unique way.

Customer preferences: Uganda has been administering the AstraZeneca vaccine, which was donated by the COVAX facility. The vaccine has been well-received by the population, and there has been a high demand for it. The government has been working to ensure that the vaccine is distributed equitably across the country, with a focus on reaching rural areas.

Trends in the market: One trend that has emerged in the COVID-19 vaccine market in Uganda is the use of mobile technology to improve vaccine distribution. The government has been using mobile phone apps to track vaccine distribution and monitor adverse reactions. This technology has helped to ensure that the vaccine is reaching those who need it most.Another trend that has emerged is the use of community health workers to increase vaccine uptake. These workers have been going door-to-door to educate people about the vaccine and to encourage them to get vaccinated. This approach has been particularly effective in rural areas, where access to healthcare is limited.

Local special circumstances: Uganda has a unique set of circumstances that have influenced the development of the COVID-19 vaccine market. One of the biggest challenges has been the country's limited healthcare infrastructure, particularly in rural areas. The government has had to work hard to ensure that the vaccine is reaching these areas and that people are getting the care they need.Another challenge has been vaccine hesitancy. Some people in Uganda have been hesitant to get vaccinated due to concerns about the safety and efficacy of the vaccine. The government has been working to address these concerns through education campaigns and community outreach.

Underlying macroeconomic factors: Uganda's economy has been heavily impacted by the COVID-19 pandemic, with many businesses and industries struggling to stay afloat. The government has been working to provide economic relief to those who have been affected by the pandemic, which has helped to mitigate some of the negative impacts.Overall, the COVID-19 vaccine market in Uganda has been developing in a unique way, with a focus on equitable distribution and the use of mobile technology and community outreach to increase vaccine uptake. While there have been challenges, the country has made significant progress in its battle against COVID-19.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.